Friday, November 8, 2019

Strides Pharma relaunches Ranitidine tablets in US

Strides Pharma relaunches Ranitidine tablets in US The company had suspended sales of its generic Ranitidine tablets after the US Food and Drug Administration (USFDA) found contamination in some Ranitidine tablets sold by various companies with potentially cancer causing impurities, NDMA.

from Moneycontrol Business News https://ift.tt/32qJ21Z

No comments:

Post a Comment

Stocks in news: Bharti Airtel, Vodafone Idea, NLC India, Motilal Oswal, HCL Tech

Indian markets saw a sharp decline on Monday amid global worries and geopolitical tensions. Nifty moved closer to a key support level. Sever...